カリフォルニア州における胃癌の臨床試験
カリフォルニア州内の拠点で、胃癌に関する69件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles22件の研究
- Baldwin Park22件の研究
- Orange13件の研究
- Mountain View12件の研究
- San Diego9件の研究
- Santa Monica9件の研究
- San Francisco8件の研究
- Irvine6件の研究
- Sacramento6件の研究
- Santa Rosa5件の研究
- Concord4件の研究
- Fullerton3件の研究
- Westminster3件の研究
- Santa Maria3件の研究
公式研究テキスト（英語）
Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- 他10件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- 他8件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07529808Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- 他20件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
- Local Institution - 0428, San Francisco
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Research Site, Orange
- Research Site, Palo Alto
- Research Site, Santa Rosa
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06219941Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- UCLA Health, Los Angeles
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07700979IKS014 in Advanced Solid Tumors That Express HER2
- Hoag Memorial Hospital Presbyterian, Newport Beach
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05872295Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- UCLA Hematology/Oncology - Atascadero, Atascadero
- UCLA Hematology/Oncology - Burbank, Burbank
- UCLA Hematology/Oncology - Encino, Encino
- 他5件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07392892Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Los Angeles
- Research Site, Santa Rosa
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
- Stanford Cancer Center, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05274048Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
- Helios CR Inc./RadNet, Cerritos
- City of Hope National Cancer Center, Duarte
- Hoag Memorial Hospital, Irvine
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07217704Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898A Phase 1/1b Study of IAM1363 in HER2 Cancers
- UCSD Moores Cancer Center, La Jolla
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Duarte
- Research Site, Fountain Valley
- Research Site, Fullerton
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- University of California San Francisco, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07070232Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07795749Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
- UCLA, Santa Monica
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07070466A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- UC San Diego Moores Cancer Center, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07227168PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- City of Hope Medical Center, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT04329494Patient-Derived Xenografts to Reduce Cancer Health Disparities
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中観察研究
21歳〜100歳 · 全性別 · 2026/08/20更新 · NCT04410302Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- University of California, San Francisco, San Francisco
- John Muir Medical Center-Walnut Creek, Walnut Creek
被験者募集中
18歳以上 · 全性別 · 2026/08/14更新 · NCT04221893A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- ULCA, Los Angeles
- UCSF, San Francisco
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/13更新 · NCT07066657A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- UCSD, La Jolla
- Sharp Healthcare, San Diego
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- City of Hope, Duarte
- Los Angeles Cancer Network, Glendale
- California Research Institute, Los Angeles
- 他3件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #101, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06974110A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- University of California Davis Comprehensive Cancer Center, Sacramento
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT05208762A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- IP Address: City of Hope Investigational Drug Services(IDS), Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT06131840A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- City of Hope, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06580002A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- City of Hope Nat Medical Ctr, Duarte
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/07更新 · NCT07224750ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。